Press release
Global Intradermal Injection Market to Reach US$ 10.93 Billion by 2034 with 13% CAGR Growth
The global intradermal injection market is estimated to reach US$ 3.22 billion in 2024 and is projected to grow at a CAGR of 13%, attaining a value of US$ 10.93 billion by 2034.The intradermal injection market is gaining traction as an essential segment within the healthcare industry, primarily used for vaccinations, diagnostic tests, and therapeutic applications. Intradermal injections are administered into the dermis layer of the skin, offering advantages such as improved immune response and reduced dosage requirements. With increasing focus on preventive healthcare and advancements in drug delivery techniques, the market is experiencing significant growth.
Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=3880
Market Insights
The market is witnessing a shift toward minimally invasive procedures, with intradermal injections emerging as a preferred method for vaccine administration, particularly in dermatology and allergy testing. The rising prevalence of infectious diseases, coupled with increasing awareness about immunization, is fueling market demand. Additionally, technological advancements in needle-free injection systems and microneedles are enhancing the precision and safety of intradermal injections, further boosting market growth.
Market Outlook
The future of the intradermal injection market looks promising, with a surge in research and development efforts aimed at improving drug delivery mechanisms. Pharmaceutical companies and healthcare providers are increasingly focusing on intradermal administration for targeted therapies, particularly in oncology and immunotherapy. Regulatory approvals for new intradermal injection devices and vaccines are expected to drive market expansion, ensuring broader accessibility to advanced healthcare solutions.
Market Demand
Growing demand for efficient and cost-effective drug delivery methods is a key driver of the intradermal injection market. The increasing adoption of intradermal vaccines, particularly for tuberculosis and influenza, is contributing to the market's expansion. Additionally, the development of novel biologics and personalized medicine solutions is generating a higher demand for precise and controlled intradermal administration techniques.
List of Key Companies Profiled in The Report
BD (Becton, Dickinson, and Company)
OraSure Technologies Inc.
AstraZeneca
Thermo Fisher Scientific
West Pharmaceutical Services, Inc
Others
Market Opportunities
There are significant growth opportunities in the intradermal injection market, particularly in emerging economies where healthcare infrastructure is expanding. Innovations such as microneedle patches and self-administration devices present lucrative prospects for market players. Collaborations between pharmaceutical firms and medical device manufacturers can further drive advancements in intradermal delivery systems, ensuring greater market penetration and accessibility.
Recent Industry News
Recent industry news highlights major developments in intradermal injection technology, including the introduction of advanced needle-free injection devices. Several companies have received regulatory approvals for innovative intradermal vaccines, particularly for infectious diseases and skin conditions. Industry players are actively investing in research to enhance the efficiency and safety of intradermal administration, addressing concerns related to patient comfort and precision.
Notable Developments
Notable developments in the market include the adoption of smart drug delivery technologies, enabling improved therapeutic outcomes. The integration of digital health solutions, such as connected injection devices, is revolutionizing patient monitoring and compliance. Additionally, increasing clinical trials and strategic partnerships between key stakeholders are driving innovation, ensuring the continuous evolution of intradermal injection techniques. As the market advances, ongoing technological progress and regulatory support are expected to shape its future trajectory.
Want Full Report? Enquire Here-https://www.factmr.com/report/3880/intradermal-injections-market
Competitive Landscape
The market analysis integrates first-hand information, expert insights, and qualitative and quantitative assessments from industry analysts and key stakeholders across the value chain. It offers a comprehensive evaluation of parent market trends, macroeconomic indicators, and key influencing factors. Additionally, the report examines market attractiveness across segments and geographies, mapping the qualitative impact of various market dynamics on overall industry growth.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR:
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Intradermal Injection Market to Reach US$ 10.93 Billion by 2034 with 13% CAGR Growth here
News-ID: 3879311 • Views: …
More Releases from Fact.MR

Intelligent Transport System Market is Evaluatedto Reach USD 63.77 Billion by 20 …
Fact.MR today released its latest report on the Intelligent Transport System (ITS) Market, projecting robust growth driven by increasing urbanization, rising demand for efficient traffic management, and advancements in smart mobility technologies. Valued at USD 30.66 billion in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 7.6%, reaching USD 63.77 billion by 2034. This significant growth underscores the critical role of ITS…

Digital Door Lock System Market is Growing at a CAGR of 16% by 2034 | Key Player …
Digital Door Lock System Market is valued at USD 11 billion in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 16%, reaching USD 48.7 billion by 2034. This remarkable growth is driven by the increasing popularity of smart homes, which integrate advanced security features for enhanced convenience and protection. Digital door lock systems, utilizing technologies like biometrics and wireless connectivity, offer keyless entry, remote…

Electronic Access Control Systems Market is Estmated to Reach USD 32.5 Billion b …
The global electronic access control systems market is valued at USD 14.64 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 8.3%, reaching USD 32.5 billion by 2033. This growth is driven by the increasing need for advanced security solutions amid rising threats of terrorism, break-ins, and data breaches. Electronic access control systems, encompassing biometrics, card-based, keypad, intruder alarm, and perimeter security technologies,…

Neurology Devices Market is Estimated to Reach USD 22,335.5 Million by 2035 | Fa …
Neurology Devices Market was valued at USD 10,944.3 million in 2024 and is forecasted to expand at a CAGR of 6.7%, reaching USD 22,335.5 million by 2035. This growth reflects the increasing demand for advanced diagnostic and therapeutic tools to address neurological disorders, including Alzheimer's disease, Parkinson's disease, major depression, epilepsy, spinal cord injury, and traumatic brain injury. Neurology devices play a crucial role in diagnosing, preventing, and treating these…
More Releases for Intradermal
Intradermal Injection Market 2031 Size, Share | Industry Trends, Business Revenu …
Global Intradermal Injection Market Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00019998/?utm_source=OpenPR&utm_medium=10866
Key Players Analysis:
BD
Terumo Corporation
NanoPass
Pharmajet
Idevax
Eunsung Global
West Pharmaceutical Services Inc
Crossject
Cardinal Health Inc
Hindustan Syringes and Medical Devices Ltd
The report covers key developments in the Intradermal Injection Market as organic and inorganic growth strategies. Various companies are focusing…
Intradermal Injection Market Size, Growth, Statistics And Forecast 2028
According to Premium Market Insights new research study on "Intradermal Injection Market is projected to reach US$ 7,415.70 million by 2028 from US$ 3,513.26 million in 2021 and is expected to register a CAGR of 11.3% from 2021 to 2028.
Get a Sample Copy of This Report@ https://www.premiummarketinsights.com/sample/TIP00073620/?utm_source=OpenPR&utm_medium=10655
Some Of the Major Players Influencing are BD, West Pharmaceuticals Services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Ensung Global, Crossject, Cardinal Health, Hindustan Syringes and…
Global Microneedles for Trans & Intradermal Drug Delivery Market - Opportunities …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global microneedles for trans & intradermal drug delivery market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek…
Intradermal injection Market 2022 - Detailed Analysis and Forecast to 2028
The Intradermal injection Market research report by The Insight Partners includes Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2022 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the Intradermal injection Market growth.
Get a…
North America Intradermal Injections Market Revenue Forecast, Company Share, and …
The North America Intradermal Injections market is expected to reach US$ 116.80 million in 2028 from US$ 67.92 million in 2021; it is estimated to grow at a CAGR of 8.8% from 2021-2028.
The Business Market Insights provides you regional research analysis on North America Intradermal Injections Market. The research report provides deep insights into the regional market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness…
Intradermal injection Market to Reach Over $7,415.70 million by 2028
The Intradermal injection market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
The intradermal injection market is projected to reach US$ 7,415.70 million by 2028 from…